1Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc Interv, 2002,56:508-515.
2Milo S, Ho SY, Wilkinson JL, et al. Surgical anatomy and atrioventricular conduction tissues of hearts with isolated ventricular septal defects. J Thorac Cardiovasc Surg, 1980,79:244-255.
3Lock JE, Block PC, Mckay RG, et al. Transcatheter closure of ventricular septal defects. Circulation, 1988,78:361-368.
4Thanopoulos BD, Tsaousis GS, Karanasios E, et al. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occluder: preliminary experience in children. Heart, 2003,89:918-922.
6Wright E.Therapeutic plasma exchange in children.Paediatr Nurs,2004,16(9):39-42.
7Shingu Y,Aoki H,Ebuoka N,et al.A surgical case for severe hemolytic anemia after mitral valve repair.Ann Thorac Cardiovasc Surg,2005,11(3):198-200.
8Larson DF,Elkund DK,Arabia F,et al.Plasmapheresis during cardiopulmonary bypass:a proposed treatment for presensitized cardiac transplantation patients.J Extra Corpor Technol,1999,31(4):177-183.
9Ishibashi N,Kasegawa H,Koyanagi T,et al.Mechanism of hemolysis after mitral valve repair and new surgical management:prosthetic annuloplasty ring covered with autologous pericardium.J Heart Valve Dis,2005,14(5):588-591.
10Misawa Y,Konishi H,Saito T,et al.Paravalvular leakage causing hemolytic anemia at 8-9 years after mitral valve replacement.Jpn J Thorac Cardiovasc Surg,2002,50(12):530-532.
